BlueStar® Genomic Health Care Index
The BlueStar Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.
|Size and Liquidity Requirements||Float-adjusted market capitalization of at least 300 mln USD. Six-month average-daily-value-traded of at least 200000 USD.|
|Universe||Companies developing or producing gene-based healthcare technologies and therapies.|
|Diversification||Companies are liquidity weighted.|
|Review||Semi-annual in June and December.|
||BlueStar® Genomic Health Care Price Index
||BlueStar® Genomic Health Care Total Return Net Index